Diagnosis and Management of Gastric Intestinal Metaplasia: Current Status and Future Directions
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Gastric intestinal metaplasia (GIM) is a known premalignant condition of the human stomach along the pathway to gastric cancer (GC). Histologically, GIM represents the replacement of normal gastric mucosa by mucin-secreting intestinal mucosa. Helicobacter pylori infection is the most common etiologic agent of GIM development worldwide. The prevalence of GIM is heterogeneous among different regions of the world and correlates with the population endemicity of H. pylori carriage, among other environmental factors. GC remains the third leading cause of cancer-related mortality globally. GIM is usually diagnosed by upper endoscopy with biopsy, and histologic scoring systems have been developed to riskstratify patients at highest risk for progression to GC. Several recent endoscopic imaging modalities may improve the optical detection of GIM and early GC. Appropriate surveillance of GIM may be cost effective and represents an opportunity for the early diagnosis and therapy of GC. Certain East Asian nations have established population-level programs for the screening and surveillance of GIM; guidelines regarding GIM surveillance have also recently been published in Europe. By contrast, few data exist regarding the appropriateness of surveillance of GIM in the United States. In this review, we discuss the pathogenesis, epidemiology, diagnosis, and management of GIM with an emphasis on the role of appropriate endoscopic surveillance.
Abstract
Gastric intestinal metaplasia (GIM) is a known premalignant condition of the human stomach along the pathway to gastric cancer (GC). Histologically, GIM represents the replacement of normal gastric mucosa by mucin-secreting intestinal mucosa. Helicobacter pylori infection is the most common etiologic agent of GIM development worldwide. The prevalence of GIM is heterogeneous among different regions of the world and correlates with the population endemicity of H. pylori carriage, among other environmental factors. GC remains the third leading cause of cancer-related mortality globally. GIM is usually diagnosed by upper endoscopy with biopsy, and histologic scoring systems have been developed to riskstratify patients at highest risk for progression to GC. Several recent endoscopic imaging modalities may improve the optical detection of GIM and early GC. Appropriate surveillance of GIM may be cost effective and represents an opportunity for the early diagnosis and therapy of GC. Certain East Asian nations have established population-level programs for the screening and surveillance of GIM; guidelines regarding GIM surveillance have also recently been published in Europe. By contrast, few data exist regarding the appropriateness of surveillance of GIM in the United States. In this review, we discuss the pathogenesis, epidemiology, diagnosis, and management of GIM with an emphasis on the role of appropriate endoscopic surveillance.
참고문헌 (56)
- Yo Han Park, "Review of Atrophic Gastritis and Intestinal Metaplasia as a Premalignant Lesion of Gastric Cancer", 대한암예방학회지, 20(1), pp.25~40 (2015), 대한암예방학회[DOI]
- ASGE Standards of Practice Committee, "The role of endoscopy in the management of premalignant and malignant conditions of the stomach", Gastrointest Endosc, 82, pp.1~8 (2015)
- 김상균, "한국인 헬리코박터 파일로리 감염의 진단과 치료 임상 진료지침 개정안 2013", 대한소화기학회지, 62(1), pp.3~26 (2013), 대한소화기학회
- Leung WK, "Review article : intestinal metaplasia and gastric carcinogenesis", Aliment Pharmacol Ther, 16, pp.1209~1216 (2002)
- Uemura N, "Helicobacter pylori infection and the development of gastric cancer", N Engl J Med, 345, pp.784~789 (2001)
- Sipponen P, "Intestinal metaplasia, atrophic gastritis and stomach cancer : trends over time", Eur J Gastroenterol Hepatol, 6, pp.S79~S83 (1994)
- 임지환, "Correlation between Endoscopic and Histological Diagnoses of Gastric Intestinal Metaplasia", Gut and Liver, 7(1), pp.41~45 (2013), 거트앤리버 소화기연관학회협의회
- Marques-Silva L, "Prevalence of gastric precancerous conditions : a systematic review and metaanalysis", Eur J Gastroenterol Hepatol, 26, pp.378~387 (2014)
- Fennerty MB, "Gastric intestinal metaplasia on routine endoscopic biopsy", Gastroenterology, 125, pp.586~590 (2003)
- Song H, "Incidence of gastric cancer among patients with gastric precancerous lesions: observational cohort study in a low risk Western population", BMJ, 351, pp.h3867~ (2015)
- Torre LA, "Global cancer statistics, 2012", CA Cancer J Clin, 65, pp.87~108 (2015)
- Correa P, "Human gastric carcinogenesis: a multistep and multifactorial process. First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention", Cancer Res, 52, pp.6735~6740 (1992)
- Ishaq S, "Helicobacter pylori and gastric cancer : a state of the art review", Gastroenterol Hepatol Bed Bench, 8, pp.S6~S14 (2015)
- Goh KL, "Epidemiology of Helicobacter pylori infection and public health implications", Helicobacter, 16, pp.1~9 (2011)
- Eslick GD, "Association of Helicobacter pylori infection with gastric carcinoma : a meta-analysis", Am J Gastroenterol, 94, pp.2373~2379 (1999)
- Peleteiro B, "Prevalence of Helicobacter pylori infection worldwide : a systematic review of studies with national coverage", Dig Dis Sci, 59, pp.1698~1709 (2014)
- Li N, "Transforming growth factor-beta : an important mediator in Helicobacter pylori-associated pathogenesis", Front Cell Infect Microbiol, 5, pp.77~ (2015)
- Sue S, "Helicobacter pylori-induced signaling pathways contribute to intestinal metaplasia and gastric carcinogenesis", Biomed Res Int, 2015, pp.737621~ (2015)
- Valenzuela MA, "Helicobacter pylori-induced inflammation and epigenetic changes during gastric carcinogenesis", World J Gastroenterol, 21, pp.12742~12756 (2015)
- Ford AC, "Helicobacter pylori eradication for the prevention of gastric neoplasia", Cochrane Database Syst Rev, (7), pp.CD005583~ (2015)
- Ford AC, "Helicobacter pylori eradication therapy to prevent gastric cancer in healthy asymptomatic infected individuals: systematic review and metaanalysis of randomised controlled trials", BMJ, 348, pp.g3174~ (2014)
- Asaka M, "Guidelines for the management of Helicobacter pylori infection in Japan : 2009 revised edition", Helicobacter, 15, pp.1~20 (2010)
- Yeh JM, "Exploring the costeffectiveness of Helicobacter pylori screening to prevent gastric cancer in China in anticipation of clinical trial results", Int J Cancer, 124, pp.157~166 (2009)
- Rugge M, "Precancerous lesions in the stomach : from biology to clinical patient management", Best Pract Res Clin Gastroenterol, 27, pp.205~223 (2013)
- Ahn HJ, "Helicobacter pylori in gastric carcinogenesis", World J Gastrointest Oncol, 7, pp.455~465 (2015)
- Zhu H, "Red and processed meat intake is associated with higher gastric cancer risk : a meta-analysis of epidemiological observational studies", PLoS One, 8, pp.e70955~ (2013)
- Zhong C, "Sodium intake, salt taste and gastric cancer risk according to Helicobacter pylori infection, smoking, histological type and tumor site in China", Asian Pac J Cancer Prev, 13, pp.2481~2484 (2012)
- Ladeiras-Lopes R, "Smoking and gastric cancer : systematic review and meta-analysis of cohort studies", Cancer Causes Control, 19, pp.689~701 (2008)
- González CA, "Smoking and the risk of gastric cancer in the European Prospective Investigation Into Cancer and Nutrition(EPIC)", Int J Cancer, 107, pp.629~634 (2003)
- Turati F, "A meta-analysis of body mass index and esophageal and gastric cardia adenocarcinoma", Ann Oncol, 24, pp.609~617 (2013)
- Yang P, "Overweight, obesity and gastric cancer risk : results from a meta-analysis of cohort studies", Eur J Cancer, 45, pp.2867~2873 (2009)
- Dixon MF, "Classification and grading of gastritis: the updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994", Am J Surg Pathol, 20, pp.1161~1181 (1996)
- Rugge M, "Gastritis staging in clinical practice : the OLGA staging system", Gut, 56, pp.631~636 (2007)
- Rugge M, "Gastritis OLGA-staging and gastric cancer risk : a twelve-year clinico-pathological follow-up study", Aliment Pharmacol Ther, 31, pp.1104~1111 (2010)
- Capelle LG, "The staging of gastritis with the OLGA system by using intestinal metaplasia as an accurate alternative for atrophic gastritis", Gastrointest Endosc, 71, pp.1150~1158 (2010)
- Filipe MI, "Incomplete sulphomucinsecreting intestinal metaplasia for gastric cancer. Preliminary data from a prospective study from three centres", Gut, 26, pp.1319~1326 (1985)
- Filipe MI, "Intestinal metaplasia types and the risk of gastric cancer : a cohort study in Slovenia", Int J Cancer, 57, pp.324~329 (1994)
- Piazuelo MB, "Phenotypic differences between esophageal and gastric intestinal metaplasia", Mod Pathol, 17, pp.62~74 (2004)
- Mirza ZK, "Gastric intestinal metaplasia as detected by a monoclonal antibody is highly associated with gastric adenocarcinoma", Gut, 52, pp.807~812 (2003)
- Tanaka H, "Expression of small intestinal and colonic phenotypes in complete intestinal metaplasia of the human stomach", Virchows Arch, 447, pp.806~815 (2005)
- Schlemper RJ, "The Vienna classification of gastrointestinal epithelial neoplasia", Gut, 47, pp.251~255 (2000)
- Dinis-Ribeiro M, "Management of precancerous conditions and lesions in the stomach(MAPS) : guideline from the European Society of Gastrointestinal Endoscopy(ESGE), European Helicobacter Study Group(EHSG), European Society of Pathology(ESP), and the Sociedade Portuguesa de Endoscopia Digestiva(SPED)", Virchows Arch, 460, pp.19~46 (2012)
- Kikuste I, "Systematic review of the diagnosis of gastric premalignant conditions and neoplasia with high-resolution endoscopic technologies", Scand J Gastroenterol, 48, pp.1108~1117 (2013)
- Osawa H, "Present and future status of flexible spectral imaging color enhancement and blue laser imaging technology", Dig Endosc, 26, pp.105~115 (2014)
- Pimentel-Nunes P, "A multicenter validation of an endoscopic classification with narrow band imaging for gastric precancerous and cancerous lesions", Endoscopy, 44, pp.236~246 (2012)
- Pimentel-Nunes P, "A multicenter prospective study of the real-time use of narrow-band imaging in the diagnosis of premalignant gastric conditions and lesions", Endoscopy, 48, pp.723~730 (2016)
- Capelle LG, "Narrow band imaging for the detection of gastric intestinal metaplasia and dysplasia during surveillance endoscopy", Dig Dis Sci, 55, pp.3442~3448 (2010)
- Taghavi SA, "Comparison of chromoendoscopy and conventional endoscopy in the detection of premalignant gastric lesions", Can J Gastroenterol, 23, pp.105~108 (2009)
- Dinis-Ribeiro M, "Chromoendoscopy for early diagnosis of gastric cancer", Eur J Gastroenterol Hepatol, 18, pp.831~838 (2006)
- 이준행, "Clinical Practice Guidelines for Gastric Cancer in Korea: An Evidence-Based Approach", Journal of Gastric Cancer, 14(2), pp.87~104 (2014), 대한위암학회[DOI]
- Ballester V, "Endoscopic surveillance of gastrointestinal premalignant lesions : current knowledge and future directions", Curr Opin Gastroenterol, 30, pp.477~483 (2014)
- Adam Templeton, "Confocal Microscopy in the Esophagus and Stomach", Clinical Endoscopy, 46(5), pp.445~449 (2013), 대한소화기내시경학회
- Leung WK, "Screening for gastric cancer in Asia : current evidence and practice", Lancet Oncol, 9, pp.279~287 (2008)
- Hamashima C, "Potential capacity of endoscopic screening for gastric cancer in Japan", Cancer Sci, 108, pp.101~107 (2017)
- Yoon H, "Effect of endoscopic screening at 1-year intervals on the clinicopathologic characteristics and treatment of gastric cancer in South Korea", J Gastroenterol Hepatol, 27, pp.928~934 (2012)
- Saumoy M, "Cost effectiveness of gastric cancer screening according to race and ethnicity", Gastroenterology, 155, pp.648~660 (2018)